Market Cap : 8.02 B | Enterprise Value : 6.73 B | PE Ratio : 119.51 | PB Ratio : 5.80 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Ionis Pharmaceuticals's Long-Term Debt for the quarter that ended in Sep. 2020 was $814.8 Mil.
Ionis Pharmaceuticals's quarterly Long-Term Debt increased from Mar. 2020 ($794.6 Mil) to Jun. 2020 ($804.2 Mil) and increased from Jun. 2020 ($804.2 Mil) to Sep. 2020 ($814.8 Mil).
Ionis Pharmaceuticals's annual Long-Term Debt increased from Dec. 2017 ($605.9 Mil) to Dec. 2018 ($633.0 Mil) and increased from Dec. 2018 ($633.0 Mil) to Dec. 2019 ($785.5 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.
No Headline